Navigation Links
European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreich's Ataxia by Santhera
Date:8/19/2007

diseases. Santhera's vision is to become a leading specialty pharmaceutical company offering therapies for a number of indications in this area of high unmet medical need which includes many orphan indications with no current therapy.

Santhera currently has five clinical-stage development programs, three of which are investigating its lead compound, SNT-MC17 (INN: idebenone), in the treatment of Friedreich's Ataxia (FRDA), Duchenne Muscular Dystrophy (DMD) and Leber's Hereditary Optic Neuropathy (LHON). Another clinical program is investigating JP-1730 (INN: fipamezole) for the treatment of Dyskinesia in Parkinson's Disease (DPD) in cooperation with Juvantia, the compound's owner. The fifth program comprises SNT-317 (INN: omigapil) in Congenital Muscular Dystrophies (CMD), a compound in-licensed from Novartis. The most advanced program, SNT-MC17 in FRDA, is currently in Marketing Authorization Application process in Europe and in Phase III clinical development in the US while the other clinical programs are in Phase II. For further information, please visit http://www.santhera.com.

About Takeda

Located in Osaka, Japan, Takeda (TSE:4502) is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products.

Aiming to become an "R&D-driven world-class pharmaceutical company", Takeda is enhancing its R&D pipeline by concentrating its management resources for that purpose in the following selected core therapeutic areas:

- lifestyle-related diseases,

- oncology and urological diseases

- central nervous system disorders, bone/joint diseases

- gastroenterological diseases

Additional information about Takeda is available through its
'/>"/>

SOURCE Santhera Pharmaceuticals AG

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6

Related biology technology :

1. Mirus granted European patent for gene therapy
2. Info security group announces first Eastern European chapter
3. EMD Biosciences partners with European biotech company
4. Third Wave lands European distribution deal, reports high earnings
5. Biologist who cloned Dolly the sheep believes therapeutic cloning will gain acceptance
6. Biotech crops gaining acceptance, but their full promise has yet to be fulfilled
7. Risks and returns: Building a search engine marketing portfolio
8. The write stuff: marketing with articles
9. StrandVision signs joint marketing agreement with Pacific Signage
10. CPM contributes marketing program to Michigan hospital
11. MyWeather names new president, marketing officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... DIEGO and SHENZHEN, China ... announced today the purchase of an Irys™System ... organization. BGI selected BioNano,s platform to enable comprehensive exploration ... improved assemblies for various organisms of interest, including those ... will partner together to develop new methods for multiplexing ...
(Date:7/31/2014)... 31, 2014 Although RNA-Sequencing is ... first transcriptome-wide analyses appearing around 2008, RNA-Sequencing has ... RNA measurement. In the last several years, assays ... work with smaller input amounts, process degraded RNA, ... samples). On the bioinformatics side, there have been ...
(Date:7/31/2014)... Miami, Fla. (PRWEB) July 31, 2014 The ... for distribution of its monthly news magazine, Kidney Cancer News. ... have a presence on a website maintained by an international ... noted an immediate increase in viewers.” , This month’s program ... of kidney tumors analyzed in a recent study. Kidney ...
(Date:7/30/2014)... PARIS , July 30, 2014  Regeneron ... NYSE: SNY) today announced that the Companies intend to ... pediatric disease priority review voucher in connection with the ... review voucher entitles the holder to designate a BLA ... review from the filing date instead of the standard ...
Breaking Biology Technology:BioNano Genomics Announces the Purchase of the Irys System by BGI 2BioNano Genomics Announces the Purchase of the Irys System by BGI 3BioNano Genomics Announces the Purchase of the Irys System by BGI 4The Evolution of RNA-Sequencing, Upcoming Live Webinar August 22 hosted by Xtalks 2Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 2Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 3Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 4Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 5Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 6
... as a 2010 American Chemical Society Fellowa distinguished group of ... or industry. Donna Nelson, professor in the OU Department ... ceremony at the ACS National Meeting in Boston on August ... second group of chemists to be honored for contributions to ...
... toward understanding the unique and often unexpected properties of ... because of its potential applications in future generations of ... edition of the journal Nature Physics , researchers ... Institute of Standards and Technology (NIST) describe for the ...
... State University have demonstrated the first plastic computer memory ... and write data. An alternative to traditional microelectronics, ... process data faster, and consume less power. In ... Materials , Arthur J. Epstein and colleagues describe how ...
Cached Biology Technology:Study of electron orbits in multilayer graphene finds unexpected energy gaps 2Study of electron orbits in multilayer graphene finds unexpected energy gaps 3Study of electron orbits in multilayer graphene finds unexpected energy gaps 4Researchers successfully test new alternative to traditional semiconductors 2Researchers successfully test new alternative to traditional semiconductors 3
(Date:7/31/2014)... Dr. Oren Tessler, Assistant Professor of Clinical Surgery ... Medicine, is part of a team of plastic and ... a method to screen and select patients for a ... the patients who underwent this surgery to decompress the ... a bonus cosmetic eyelid surgery. The study, which confirms ...
(Date:7/31/2014)... 31, 2014 Biometrics industry sees ... smart technologies; companies turn towards digital currency: NXT-ID, Inc. ... Amazon.com Inc. (NASDAQ: AMZN ), Facebook Inc. ... GOOG ) and Microsoft Corporation (NASDAQ: MSFT) ... the growing m-commerce market, announces a video featuring its ...
(Date:7/30/2014)... paving the way for a breakthrough that may ... exposed to poisonous chemicalsparticularly those in pesticides and ... current issue of the journal ChemBioChem ... compounds commonly used in pesticides and warfare agents. ... of Engineering Associate Professor of Chemical and Biological ...
Breaking Biology News(10 mins):Surgeons report significant migraine relief from cosmetic eyelid surgery technique 2Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 2Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 3Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 4Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 5Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 6Engineering a protein to prevent brain damage from toxic agents 2
... research at Rutgers University may help shed light on how ... people to suffer from life-threatening anxiety disorders while others are ... the Department of Genetics, and a team of researchers, found ... in the roundworm, responsible for receiving information, undergo major changes ...
... often recall their dreams respond more strongly to their name ... of human cognition. It is still not fully known when ... A major difficulty for studying dreams is that they leave ... and colleagues from the Lyon Neuroscience Research Center chose a ...
... and climate events like storms, heavy precipitation and droughts and ... by the global vegetation. A team of scientists under the ... for Biogeochemistry in Jena, Germany, investigated the effect of extremes ... the first time. In the current issue of Nature ...
Cached Biology News:Rutgers study: Worms may shed light on human ability to handle chronic stress 2Frontiers news briefs: Aug. 13 2Frontiers news briefs: Aug. 13 3Extreme weather, climate and the carbon cycle 2
Request Info...
... labware. Waterproof, moisture-proof film prevents sample ... be folded repeatedly and twisted around ... at 21C (70F), wrapping film increases ... removed, film only partially returns to ...
...
Normal human AB serum, pooled...
Biology Products: